Brief Title
Study of Abdominal Aortic Stent Grafts in the Treatment of Infrarenal Abdominal Aortic Aneurysms
Official Title
Study of Abdominal Aortic Stent Grafts in the Treatment of Infrarenal Abdo Minal Aortic Aneurysms
Brief Summary
The Vascutek Anaconda™ Stent Graft System for repair of Abdominal Aortic Aneurysms (AAA) is the subject of this observational study. 180 patients will be implanted with the Anaconda™ Stent Graft System and will be followed-up annually for 5 years post-implant. The study will satisfy the requirements of the French National Authority for Health (Haute Autorité de santé) and the data collected will be used for reimbursement renewal.
Detailed Description
Infrarenal abdominal aortic aneurysms may be treated with the introduction of an abdominal aortic stent graft via the femoral route. This technique is commonly used in high surgical risk patients but can also be suitable under certain conditions for normal risk patients. Abdominal aortic stent grafts, inserted via the femoral artery, are used to treat infrarenal abdominal aortic aneurysms, removing the need for an invasive surgical procedure. The aim of this observational study is to evaluate the long-term (5 year) benefits of the technique by documenting the overall mortality, complications (endoleak, migration), rate of surgical conversion, progression and rupture of the aneurysm in a cohort of patients who are representative of the treated population under real conditions of use.
Study Type
Observational
Primary Outcome
Overall mortality rate
Condition
Abdominal Aortic Aneurysm
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Estimated Enrollment
180
Start Date
June 2012
Completion Date
December 2019
Primary Completion Date
October 2013
Eligibility Criteria
Inclusion Criteria: - Any patient implanted with the Vascutek Anaconda™ Stent Graft System for the treatment of a non-ruptured infrarenal Abdominal Aortic Aneurysm (AAA) Exclusion Criteria: - Patients for whom clinical follow-up is impossible and cannot return for check-up visits
Gender
All
Ages
18 Years - N/A
Accepts Healthy Volunteers
No
Contacts
Professor Dominique Midy, ,
Location Countries
France
Location Countries
France
Administrative Informations
NCT ID
NCT01783184
Organization ID
EPI-ANA01
Responsible Party
Sponsor
Study Sponsor
Vascutek Ltd.
Study Sponsor
Professor Dominique Midy, Principal Investigator, Groupe Hospitalier Pellegrin , Bordeaux, France
Verification Date
October 2020